Edition:
India

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

16.18USD
22 Sep 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$16.18
Open
$16.05
Day's High
$16.35
Day's Low
$15.44
Volume
93,817
Avg. Vol
145,201
52-wk High
$31.67
52-wk Low
$6.95

Select another date:

Sat, Jun 27 2020

BRIEF-Cue Biopharma Entered Into Second Amendment To License Agreement With Mil 21E Dated Jan. 19, 2018

* CUE BIOPHARMA- ON JUNE 24, ENTERED INTO SECOND AMENDMENT TO LICENSE AGREEMENT TO ITS LICENSE AGREEMENT WITH MIL 21E, LLC DATED JAN. 19, 2018

BRIEF-Cue Biopharma Says Entered At-The-Market Equity Offering Sales Agreement With Stifel, Nicolaus & Company, To Offer, Sell Up To $40 Mln Of Common Stock

* CUE BIOPHARMA - ENTERED AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT WITH STIFEL, NICOLAUS & COMPANY, TO OFFER, SELL UP TO $40 MILLION OF COMMON STOCK Source: https://bit.ly/3fP2U5U Further company coverage:

BRIEF-Cue Biopharma Provides Update On Ongoing Phase 1 Trial Evaluating CUE-101 In Metastatic Head And Neck Cancer

* CUE BIOPHARMA PROVIDES UPDATE ON ONGOING PHASE 1 TRIAL EVALUATING CUE-101 IN RECURRENT/METASTATIC HEAD AND NECK CANCER

BRIEF-Cue Biopharma Reports Qtrly Loss Per Share Of $0.48

* CUE BIOPHARMA REPORTS FIRST QUARTER 2020 RESULTS, UPDATES OF CUE-101 PHASE 1 DOSE ESCALATION STUDY AND RECENT BUSINESS HIGHLIGHTS

BRIEF-Cue Biopharma Announces Strategic Research Collaboration With Dr. Michael Dustin And Oxford University

* CUE BIOPHARMA ANNOUNCES STRATEGIC RESEARCH COLLABORATION WITH DR. MICHAEL DUSTIN AND OXFORD UNIVERSITY Source text for Eikon: Further company coverage:

BRIEF-Cue Biopharma Announces Clinical Trial Collaboration Agreement With Merck

* CUE BIOPHARMA ANNOUNCES CLINICAL TRIAL COLLABORATION AGREEMENT WITH MERCK TO EVALUATE CUE-101 IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) AS FIRST-LINE TREATMENT FOR HPV+ RECURRENT/METASTATIC HEAD AND NECK CANCER

BRIEF-Cue Biopharma Files For Common Stock Offering Of Up To $35.0 Mln - SEC Filing

* CUE BIOPHARMA INC FILES FOR COMMON STOCK OFFERING OF UP TO $35.0 MILLION - SEC FILING Source : (https://bit.ly/2UoJehu) Further company coverage:

Select another date: